lycorine has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bingham, TW; Dulanto, SA; Evidente, A; Hernandez, LW; Kornienko, A; Lafontaine, DLJ; Laguera, B; Lane, MA; Masi, M; Mathieu, V; Sarlah, D | 1 |
| Ferreira, MU; Sancha, SAR; Spengler, G; Szemerédi, N | 1 |
2 other study(ies) available for lycorine and Colonic Neoplasms
| Article | Year |
|---|---|
Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer Cells.
Topics: Alkaloids; Amaryllidaceae Alkaloids; Cell Line; Cell Proliferation; Colonic Neoplasms; Cytokines; Humans; Matrix Metalloproteinase 1; Phenanthridines; Vascular Endothelial Growth Factor A | 2022 |
Lycorine Carbamate Derivatives for Reversing P-glycoprotein-Mediated Multidrug Resistance in Human Colon Adenocarcinoma Cells.
Topics: Adenocarcinoma; Amaryllidaceae Alkaloids; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Carbamates; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans | 2023 |